tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AGRX

Agile Therapeutics Embarks on New Chapter Post-Merger
Company AnnouncementsAgile Therapeutics Embarks on New Chapter Post-Merger
4M ago
8K
AGRX
Agile Therapeutics Merges with Insud Pharma Subsidiary
PremiumCompany Announcements
Agile Therapeutics Merges with Insud Pharma Subsidiary
6M ago
8K
AGRX
Agile Therapeutics to be acquired by Insud Pharma for $1.52 per share in cash
PremiumThe Fly
Agile Therapeutics to be acquired by Insud Pharma for $1.52 per share in cash
6M ago
AGRX
Agile Therapeutics Releases Updated Investor Presentation
PremiumCompany Announcements
Agile Therapeutics Releases Updated Investor Presentation
9M ago
8K
AGRX
Agile Therapeutics’ Balancing Act: Funding Challenges Threaten R&D and Twirla Rollout
PremiumCompany Announcements
Agile Therapeutics’ Balancing Act: Funding Challenges Threaten R&D and Twirla Rollout
9M ago
AGRX
Agile Therapeutics reports Q4 EPS ($1.51) vs (10c) last year
PremiumThe FlyAgile Therapeutics reports Q4 EPS ($1.51) vs (10c) last year
9M ago
AGRX
AGRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AGRX Upcoming Earnings Report: What to Expect?
9M ago
AGRX
Agile Therapeutics announces delisting from Nasdaq
Premium
The Fly
Agile Therapeutics announces delisting from Nasdaq
9M ago
AGRX
Agile Therapeutics cut to Hold at Maxim on revenue miss, likely cash needs
PremiumThe Fly
Agile Therapeutics cut to Hold at Maxim on revenue miss, likely cash needs
9M ago
AGRX
Agile Therapeutics downgraded to Hold from Buy at Maxim
PremiumThe Fly
Agile Therapeutics downgraded to Hold from Buy at Maxim
9M ago
AGRX
Agile Therapeutics completes payoff of debt
PremiumThe Fly
Agile Therapeutics completes payoff of debt
9M ago
AGRX
Agile Therapeutics Secures Funding Through Warrant Transactions
PremiumCompany Announcements
Agile Therapeutics Secures Funding Through Warrant Transactions
10M ago
8K
AGRX
Agile Therapeutics announces exercise of warrants for $4.8M gross proceeds
PremiumThe FlyAgile Therapeutics announces exercise of warrants for $4.8M gross proceeds
10M ago
AGRX
Agile Therapeutics Gains Extension on Loan and Nasdaq Compliance
Premium
Company Announcements
Agile Therapeutics Gains Extension on Loan and Nasdaq Compliance
10M ago
8K
AGRX
Agile Therapeutics granted extension by Nasdaq to regain compliance
Premium
The Fly
Agile Therapeutics granted extension by Nasdaq to regain compliance
10M ago
AGRX
Agile Therapeutics notes Biden administration guidance on contraceptive access
PremiumThe Fly
Agile Therapeutics notes Biden administration guidance on contraceptive access
11M ago
AGRX
Agile provides update on actions to strength ACA’s no-cost contraceptive rule
PremiumThe Fly
Agile provides update on actions to strength ACA’s no-cost contraceptive rule
1y ago
AGRX
Agile Therapeutics files to sell $15M of common stock, Series E-1 warrants
PremiumThe Fly
Agile Therapeutics files to sell $15M of common stock, Series E-1 warrants
1y ago
AGRX
Agile Therapeutics reports Q3 EPS ($1.47) vs ($3.10) last year
PremiumThe Fly
Agile Therapeutics reports Q3 EPS ($1.47) vs ($3.10) last year
1y ago
AGRX
Is AGRX a Buy, Before Earnings?
PremiumPre-EarningsIs AGRX a Buy, Before Earnings?
1y ago
AGRX
Wayfair upgraded, Deere downgraded: Wall Street’s top analyst calls
Premium
The Fly
Wayfair upgraded, Deere downgraded: Wall Street’s top analyst calls
1y ago
W
DE
Agile Therapeutics upgraded to Buy from Hold at Maxim
Premium
The Fly
Agile Therapeutics upgraded to Buy from Hold at Maxim
1y ago
AGRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >